Beauveria bassiana Bbsre1 gene knockout strain and application thereof
By constructing and transforming a BbSre1 gene knockout strain of Beauveria bassiana, the SREBP transcription factor BbSre1 was disrupted, promoting the production of antibacterial substances. This solved the problem of the difficulty in discovering the hidden secondary metabolites, achieving effective inhibition of plant pathogenic fungi and expanding the application of Beauveria bassiana.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHONGQING UNIV OF TRADITIONAL CHINESE MEDICINE
- Filing Date
- 2026-04-23
- Publication Date
- 2026-07-24
AI Technical Summary
Existing technologies are insufficient to effectively discover latent secondary metabolites in Beauveria bassiana, which limits the development and application of new drugs. Furthermore, there is a lack of methods for screening latent secondary metabolites using gene knockout induction.
By constructing a recombinant vector expressing the homologous arm of the BbSre1 gene, transforming it into wild-type Beauveria bassiana, screening out the BbSre1 gene knockout strain ΔBbSre1, and obtaining a mutant strain using homologous recombination, the coding region of the SREBP transcription factor BbSre1 was disrupted, promoting the production of antibacterial substances.
The ΔBbSre1 strain showed significant inhibitory effects on plant pathogenic fungi such as gray mold, rapeseed black spot fungus, and Fusarium graminearum, expanding the application scope of Beauveria bassiana and providing a new approach for fungicide development.
Smart Images

Figure CN122445684A_ABST